EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The impact of COVID‐19 on medication reviews in English primary care. An OpenSAFELY‐TPP analysis of 20 million adult electronic health records

OpenSAFELY Collaborative, Christopher Wood iD, Victoria Speed iD, Louis Fisher iD, Helen J Curtis iD, Andrea L Schaffer iD, Alex J Walker iD, Richard Croker iD, Andrew D Brown iD, Christine Cunningham iD, William J Hulme iD, Colm D Andrews iD und 20 weitere

British Journal of Clinical Pharmacology · 2024-07 · 90 (7) · 1600-1614

DOI: 10.1111/bcp.16030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 26.03.2024. Verfasst von OpenSAFELY Collaborative und 31 weiteren Autor:innen. Beteiligte Einrichtung: Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: COVID-19, Electronic Health Records, Primary Health Care. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Data Research UK, Wellcome Trust, NIHR funded CONVALESCENCE programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The COVID‐19 pandemic caused significant disruption to routine activity in primary care. Medication reviews are an important primary care activity ensuring safety and appropriateness of prescribing. A disruption could have significant negative implications for patient care. Using routinely collected data, our aim was first to describe codes used to record medication review activity and then to report the impact of COVID‐19 on the rates of medication reviews.

Methods

With the approval of NHS England, we conducted a cohort study of 20 million adult patient records in general practice, in‐situ using the OpenSAFELY platform. For each month, between April 2019 and March 2022, we report the percentage of patients with a medication review coded monthly and in the previous 12 months with breakdowns by regional, clinical and demographic subgroups and those prescribed high‐risk medications.

Results

In April 2019, 32.3% of patients had a medication review coded in the previous 12 months. During the first COVID‐19 lockdown, monthly activity decreased (−21.1% April 2020), but the 12‐month rate was not substantially impacted (−10.5% March 2021). The rate of structured medication review in the last 12 months reached 2.9% by March 2022, with higher percentages in high‐risk groups (care home residents 34.1%, age 90+ years 13.1%, high‐risk medications 10.2%). The most used medication review code was Medication review done 314530002 (59.5%).

Conclusions

There was a substantial reduction in the monthly rate of medication reviews during the pandemic but rates recovered by the end of the study period. Structured medication reviews were prioritized for high‐risk patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Electronic Health RecordsPrimary Health CareHumansEnglandAdultMiddle AgedMaleFemaleAgedCohort StudiesSARS-CoV-2Young AdultAged, 80 and overState Medicine

Stichwörter der Autor:innen

general practiceprescribingprimary care

Autor:innen und Institutionen

  • Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Department of Thrombosis and Haemostasis, King's College Hospital, London, UK.
  • TPP, Leeds, Horsforth, UK.

ORCID-Profile: Christopher Wood, Victoria Speed, Louis Fisher, Helen J Curtis, Andrea L Schaffer, Alex J Walker, Richard Croker, Andrew D Brown, Christine Cunningham, William J Hulme, Colm D Andrews, David Evans, Peter Inglesby, Sebastian C J Bacon, Simon Davy, Tom Ward, George Hickman, Lucy Bridges, Thomas O'Dwyer, Steven Maude, Amir Mehrkar, Chris Bates, Jonathan Cockburn, Ben Goldacre, Brian MacKenna

Förderung

  • Health Data Research UK
  • Wellcome Trust
  • NIHR funded CONVALESCENCE programme
  • Medical Research Council
  • Department of Health
  • UK Research and Innovation
  • UK National Core Studies Programme

Zitieren

APA

OpenSAFELY Collaborative, Wood, C., Speed, V., Fisher, L., Curtis, H. J., Schaffer, A. L., Walker, A. J., Croker, R., Brown, A. D., Cunningham, C., Hulme, W. J., Andrews, C. D., Butler-Cole, B. F. C., Evans, D., Inglesby, P., Dillingham, I., Bacon, S. C. J., Davy, S., Ward, T., …, & MacKenna, B. (2024). The impact of COVID‐19 on medication reviews in English primary care. An OpenSAFELY‐TPP analysis of 20 million adult electronic health records. British Journal of Clinical Pharmacology, 90(7), 1600-1614. https://doi.org/10.1111/bcp.16030

Vancouver

OpenSAFELY Collaborative, Wood C, Speed V, Fisher L, Curtis HJ, Schaffer AL, et al. The impact of COVID‐19 on medication reviews in English primary care. An OpenSAFELY‐TPP analysis of 20 million adult electronic health records. British Journal of Clinical Pharmacology. 2024;90(7):1600-1614. doi:10.1111/bcp.16030

BibTeX
@article{OpenSAFELYCollaborative2024,
  author = {OpenSAFELY Collaborative, OpenSAFELY Collaborative and Wood, Christopher and Speed, Victoria and Fisher, Louis and Curtis, Helen J and Schaffer, Andrea L and Walker, Alex J and Croker, Richard and Brown, Andrew D and Cunningham, Christine and Hulme, William J and Andrews, Colm D and Butler-Cole, Ben F C and Evans, David and Inglesby, Peter and Dillingham, Iain and Bacon, Sebastian C J and Davy, Simon and Ward, Tom and Hickman, George and Bridges, Lucy and O'Dwyer, Thomas and Maude, Steven and Smith, Rebecca M and Mehrkar, Amir and Bates, Chris and Cockburn, Jonathan and Parry, John and Hester, Frank and Harper, Sam and Goldacre, Ben and MacKenna, Brian},
  title = {The impact of COVID‐19 on medication reviews in English primary care. An OpenSAFELY‐TPP analysis of 20 million adult electronic health records},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  volume = {90},
  number = {7},
  pages = {1600--1614},
  doi = {10.1111/bcp.16030}
}
Kostenlos starten →